INTRODUCTION {#sec1-1}
============

Tumors of odontogenic origin (OTs) found in the maxillofacial region are uncommon group of tumors exhibiting heterogeneous behavior ranging from hamartomatous proliferation to malignant neoplasms with the potential of metastasis.\[[@ref1][@ref2]\] The OTs originates from epithelial and/or mesenchymal component of the tissue surrounding the teeth. The OTs are seen intraosseously in the jaw bones or extraosseously in the alveolar mucosa of the tooth-bearing apparatus.\[[@ref3][@ref4]\] It represents 1% of all the tumors of the jaw. The differences in the relative frequencies of these tumors is shown in the literature.\[[@ref3][@ref5]\]

Similar to the process of normal odontogenesis, OTs are capable of undergoing inductive mechanism where in interactions between odontogenic epithelium and ectomesenchyme takes place. Hence, the classification of OTs is introduced based on this mechanism. In 1971, the "histological typing of OTs" was first published by the World Health Organization (WHO).\[[@ref6]\] The first edition was revised and the second edition was published in the year 1992.\[[@ref7]\] In this classification, calcifying odontogenic cyst was included under OT. The third edition was published in 2005 where odontogenic keratocyst was reclassified as keratocystic OT (KCOT) with increased prevalence and distribution of OTs.\[[@ref3]\] The fourth edition was published in 2017 to simplify the terminologies and classification reflecting their proper biological behavior. It included main differences from the 3^rd^ edition (2005) introducing a new classification of odontogenic cysts, "reclassified" as OTs, and some new entities.\[[@ref8]\]

The frequency of OTs occurring in different ethnic groups from different geographical areas of the world have been documented. The frequency of these lesions is seen occurring mostly among Americans and Africans according to the available literature. Many epidemiological studies have been reported on OTs from different parts of the world, but the studies reported from the Indian subcontinent are very few. Epidemiological studies help in assessing the concern for the disease, health-care planning and estimating the quantum for reducing the disease stress. Hence, this study was performed to determine the epidemiological data, clinical and histopathological picture of the OTs diagnosed at our institute over the period of January 2008 to December 2018 with comparison of these data to the previous reports.

MATERIALS AND METHODS {#sec1-2}
=====================

A retrospective study was carried out with the permission from the institutional authorities. The archival records of the Department of Oral Pathology and Microbiology were reviewed retrospectively for all the OTs occurring in the oral cavity from January 2008 to December 2018. The study variables were age, gender, jaw, site and histopathologic features with variants of OTs. The histopathological diagnosis was made according to the 2005 WHO classification of OTs.

Statistical analysis was carried out and determination of the age, gender, jaw, site, diagnosis, variants and year-wise distribution of odontogenic lesions was taken out.

RESULTS {#sec1-3}
=======

According to the retrospective study, the age distribution showed a peak occurrence of the OT in the 1^st^--3^rd^ decennium of life. The type of lesions encountered is shown in the tabular form \[[Table 1](#T1){ref-type="table"} and [Graph 1](#F1){ref-type="fig"}\]. The most common OT diagnosed was ameloblastoma with 27% of cases occurring in the 2^nd^--3^rd^ decennium of life and 18.9% in the 3^rd^--4^th^ decennium of life \[[Table 2](#T2){ref-type="table"} and [Graph 2](#F2){ref-type="fig"}\]. Unicystic ameloblastoma (UA) which is a rare type of ameloblastoma was mostly seen in the 1^st^--2^nd^ decennium of life \[[Table 2](#T2){ref-type="table"}\]. The second-most common OT was KCOT showing equal percentage of cases, i.e., 37.5% in both 1^st^--2^nd^ and 2^nd^--3^rd^ decennium \[[Table 2](#T2){ref-type="table"}\]. Adenomatoid OT (AOT) was the third-most common tumor showing 85.7% of cases occurring in the 1^st^--2^nd^ decade \[[Table 2](#T2){ref-type="table"}\]. Odontome (O) was the fifth-most common tumor showing equal percentage, i.e., 33.3% of cases in the 1^st^--2^nd^ and 4^th^--5^th^ decennium \[[Table 2](#T2){ref-type="table"}\]. Among 93 OTs, 47 cases were seen in males and 46 cases in females, with a ratio of 1:1 \[[Table 3](#T3){ref-type="table"} and [Graph 3](#F3){ref-type="fig"}\]. All the cases diagnosed were benign except 4 cases diagnosed with ameloblastic carcinoma. According to the study, 80 cases of OTs affected the mandible and 13 cases affected maxilla, with an overall mandible: Maxilla ratio of 1:6 \[[Table 4](#T4){ref-type="table"} and [Graph 4](#F4){ref-type="fig"}\]. The mandible was most commonly affected jaw by OTs. KCOT showed high predilection with 100% occurrence in the mandibular posterior region \[[Table 5](#T5){ref-type="table"} and [Graph 5](#F5){ref-type="fig"}\]. This was followed by UA affecting the mandible with 95.2% (posterior region 90.5%) and ameloblastoma with 91.9% (posterior region 86.5%) \[[Table 5](#T5){ref-type="table"}\]. AOT showed high predilection for maxilla with 57.1% (anterior region 100%) \[[Table 5](#T5){ref-type="table"}\]. O equally affected both the maxilla and the mandible with 50% (50% anterior and 50% posterior region) \[Tables [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}\].

###### 

Type of lesions encountered

  Diagnosis       Number of lesions diagnosed   Variants
  --------------- ----------------------------- ------------------
  Ameloblastoma   37                            Hemangiomatous-1
                                                Dentinoid-1
  UA              21                            Plexiform-2
  AOT             7                             \-
  CEOT            2                             Clear cell-1
  CO              6                             \-
  OM              3                             \-
  AC              4                             \-
  OFM             1                             \-
  OF              3                             \-
  KCOT            8                             \-
  AF              1                             \-
  Total           93                            \-

UA: Unicystic ameloblastoma, AOT: Adenomatoid odontogenic tumor, CEOT: Calcifying epithelial odontogenic tumor, OM: Odontogenic myxoma, AC: Ameloblastic carcinoma, KCOT: Keratocystic Odontogenic tumor, AF: Ameloblastic fibroma, OF: Odontogenic fibro, OFM: Odontogenic fibromyxoma, CO: Compound Odontome

![Various lesions encountered](JOMFP-24-185-g001){#F1}

###### 

Age-wise distribution of odontogenic tumours

  Diagnosis       Years     Total (%)                                                            
  --------------- --------- ----------- ----------- ----------- ---------- ---------- ---------- ------------
  Ameloblastoma   0 (0.0)   5 (13.5)    10 (27.0)   7 (18.9)    6 (16.2)   3 (8.1)    6 (16.2)   37 (100.0)
  UA              1 (4.8)   7 (33.3)    6 (28.6)    2 (9.5)     0 (0.0)    4 (19.0)   1 (4.8)    21 (100.0)
  AOT             0 (0.0)   6 (85.7)    1 (14.3)    0 (0.0)     0 (0.0)    0 (0.0)    0 (0.0)    7 (100.0)
  CEOT            0 (0.0)   0 (0.0)     1 (50.0)    0 (0.0)     0 (0.0)    0 (0.0)    1 (50.0)   2 (100.0)
  O               0 (0.0)   2 (33.3)    1 (16.7)    1 (16.7)    2 (33.3)   0 (0.0)    0 (0.0)    6 (100.0)
  OM              0 (0.0)   1 (33.3)    2 (66.7)    0 (0.0)     0 (0.0)    0 (0.0)    0 (0.0)    3 (100.0)
  AC              0 (0.0)   1 (25.0)    1 (25.0)    0 (0.0)     1 (25.0)   0 (0.0)    1 (25.0)   4 (100.0)
  OFM             0 (0.0)   0 (0.0)     1 (100.0)   0 (0.0)     0 (0.0)    0 (0.0)    0 (0.0)    1 (100.0)
  OF              0 (0.0)   1 (33.3)    133.3       1 (33.3)    0 (0.0)    0 (0.0)    0 (0.0)    3 (100.0)
  KCOT            0 (0.0)   3 (37.5)    3 (37.5)    1 (12.5)    0 (0.0)    1 (12.5)   0 (0.0)    8 (100.0)
  AF              0 (0.0)   1 (100.0)   0 (0.0)     0 (0.0)     0 (0.0)    0 (0.0)    0 (0.0)    1 (100.0)
  Total           1 (1.1)   27 (29.0)   27 (29.0)   12 (12.9)   9 (9.7)    8 (8.6)    9 (9.7)    93 (100.0)

UA: Unicystic ameloblastoma, AOT: Adenomatoid odontogenic tumor, CEOT: Calcifying epithelial odontogenic tumor, OM: Odontogenic myxoma, AC: Ameloblastic carcinoma, KCOT: Keratocystic Odontogenic tumor, AF: Ameloblastic fibroma, OF: Odontogenic fibro, OFM: Odontogenic fibromyxoma, O: Odontome

![Age-wise distribution of odontogenic tumours](JOMFP-24-185-g002){#F2}

###### 

Gender-wise distribution of odontogenic tumors

  Diagnosis       Gender      Total (%)   
  --------------- ----------- ----------- ------------
  Ameloblastoma   19 (51.4)   18 (48.6)   37 (100.0)
  UA              14 (66.7)   7 (33.3)    21 (100.0)
  AOT             1 (14.3)    6 (85.7)    7 (100.0)
  CEOT            0 (0.0)     2 (100.0)   2 (100.0)
  CO              4 (66.7)    2 (33.3)    6 (100.0)
  OM              1 (33.3)    2 (66.7)    3 (100.0)
  AC              2 (50.0)    2 (50.0)    4 (100.0)
  OFM             1 (100.0)   0 (0.0)     1 (100.0)
  OF              2 (66.7)    1 (33.3)    3 (100.0)
  KCOT            3 (37.5)    5 (62.5)    8 (100.0)
  AF              0 (0.0)     1 (100.0)   1 (100.0)
  Total           47 (50.5)   46 (49.5)   93 (100.0)

UA: Unicystic ameloblastoma, AOT: Adenomatoid odontogenic tumor, CEOT: Calcifying epithelial odontogenic tumor, OM: Odontogenic myxoma, AC: Ameloblastic carcinoma, KCOT: Keratocystic Odontogenic tumor, AF: Ameloblastic fibroma, OF: Odontogenic fibro, OFM: Odontogenic fibromyxoma, CO: Compound Odontome

![Gender-wise distribution of odontogenic tumors](JOMFP-24-185-g003){#F3}

###### 

Distribution of odontogenic tumors according to the jaw affected

  Diagnosis       Jaw         Total (%)   
  --------------- ----------- ----------- ------------
  Ameloblastoma   3 (8.1)     34 (91.9)   37 (100.0)
  UA              1 (4.8)     20 (95.2)   21 (100.0)
  AOT             4 (57.1)    3 (42.9)    7 (100.0)
  CEOT            1 (50.0)    1 (50.0)    2 (100.0)
  CO              3 (50.0)    3 (50.0)    6 (100.0)
  OM              1 (33.3)    2 (66.7)    3 (100.0)
  AC              0 (0.0)     4 (100.0)   4 (100.0)
  OFM             0 (0.0)     1 (100.0)   1 (100.0)
  OF              0 (0.0)     3 (100.0)   3 (100.0)
  KCOT            0 (0.0)     8 (100.0)   8 (100.0)
  AF              0 (0.0)     1 (100.0)   1 (100.0)
  Total           13 (14.0)   80 (86.0)   93 (100.0)

UA: Unicystic ameloblastoma, AOT: Adenomatoid odontogenic tumor, CEOT: Calcifying epithelial odontogenic tumor, OM: Odontogenic myxoma, AC: Ameloblastic carcinoma, KCOT: Keratocystic Odontogenic tumor, AF: Ameloblastic fibroma, OF: Odontogenic fibro, OFM: Odontogenic fibromyxoma, CO: Compound Odontome

![Distribution of odontogenic tumors according to the jaw affected](JOMFP-24-185-g004){#F4}

###### 

Distribution of odontogenic tumors according to the site involved

  Diagnosis       Site        Total (%)   
  --------------- ----------- ----------- ------------
  Ameloblastoma   5 (13.5)    32 (86.5)   37 (100.0)
  UA              2 (9.5)     19 (90.5)   21 (100.0)
  AOT             7 (100.0)   0 (0.0)     7 (100.0)
  CEOT            1 (50.0)    1 (50.0)    2 (100.0)
  CO              3 (50.0)    3 (50.0)    6 (100.0)
  OM              0 (0.0)     3 (100.0)   3 (100.0)
  AC              0 (0.0)     4 (100.0)   4 (100.0)
  OFM             0 (0.0)     1 (100.0)   1 (100.0)
  OF              2 (66.7)    1 (33.3)    3 (100.0)
  KCOT            0 (0.0)     8 (100.0)   8 (100.0)
  AF              1 (100.0)   0 (0.0)     1 (100.0)
  Total           21 (22.6)   72 (77.4)   93 (100.0)

UA: Unicystic ameloblastoma, AOT: Adenomatoid odontogenic tumor, CEOT: Calcifying epithelial odontogenic tumor, OM: Odontogenic myxoma, AC: Ameloblastic carcinoma, KCOT: Keratocystic Odontogenic tumor, AF: Ameloblastic fibroma, OF: Odontogenic fibro, OFM: Odontogenic fibromyxoma, CO: Compound Odontome
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DISCUSSION {#sec1-4}
==========

Ameloblastoma was the most common OT diagnosed in this study with 39.7% and is similar to other studies from Asian\[[@ref9][@ref10]\] and African\[[@ref11][@ref12]\] countries. The ameloblastomas mostly affect angle and ramus region of the mandible. There are three forms of ameloblastomas, namely multicystic (solid), peripheral and unicystic type. The UA which is a rare form of ameloblastoma accounts for 22.5% and is mostly seen in the 1--2 decennium.

The prevalence of OTs has increased after the inclusion of the odontogenic keratocyst in 2005 WHO classification as KCOT. In this study, KCOT was the second most commonly occurring OT with 8.6%. The most common OT presented in the studies from the American countries was O followed by ameloblastoma.\[[@ref13][@ref14]\] In this study, odontoma is in the fourth position following ameloblastoma and KCOT, with a frequency of 6.4%. The reason behind may be the lack of routine dental checkup with radiographs in the Asian and African population. These tumors are unnoticed for years, and after surgical removal probably the specimen is not sent for histopathological examination.

AOT showed a frequency of 7.5% which is similar to studies from China.\[[@ref10][@ref15]\] AOT showed a higher frequency of 9% in the epidemiological studies from other parts of India.\[[@ref16]\] To prove whether a racial difference exists, follow-up studies are required for the occurrence of different types of OTs in a given population.

Odontogenic myxoma (OM) showed a frequency of 3.2% in this study. The value is lower compared to previous studies. OM showed a frequency of 6.5--17.7% according to the retrospective studies from Brazil,\[[@ref9]\] Nigeria,\[[@ref17]\] and Mexico.\[[@ref18]\] The frequency range of OM in China\[[@ref10]\] and Sri Lanka\[[@ref19]\] was in the range of 2.6%--4.9%. Higher frequency of OM was also shown from other Indian studies.\[[@ref16]\] The low incidence of OM needs further investigation.

According to the study, the incidence of OTs was mostly seen in the 1^st^--3^rd^ decades of life and is similar to other studies from India\[[@ref5]\] and Nigeria\[[@ref17]\] China.\[[@ref15]\] The mean age less than a decade was shown from studies of Brazil\[[@ref11]\] and Chile.\[[@ref13]\] There could be a racial difference in incidence or may be odontoma was the most common OT in those populations.

OTs showed a slight male predilection (ratio) in this study and is similar to studies from India,\[[@ref5]\] Australia,\[[@ref20]\] China.\[[@ref10][@ref15]\] Male-to-female ratio of 1:1 was shown by ameloblastoma. This is similar from studies in India,\[[@ref5]\] Nigeria\[[@ref17]\] and China.\[[@ref10]\] However, female predilection was shown from a Brazilian study.\[[@ref9]\] KCOT also showed a predilection for males which is in concordance with many other studies\[[@ref10][@ref21]\] but is not similar to a Brazilian study.\[[@ref9]\] The difference is possibly disclosed among different populations.

The jaw most commonly affected was mandible with maxilla to mandible ratio of 1:6. This is in concordance with studies from Asia\[[@ref10][@ref16]\] and Africa.\[[@ref17]\] However, the predilection for both the jaws was shown to be equal from the studies of the American continent.\[[@ref13][@ref18][@ref22]\] The reason could be the lower frequency of ameloblastoma in that particular population.

In this study, different variants of ameloblastoma and calcifying epithelial OT (CEOT) were found. Ameloblastoma like tissue with unusual formation of dentinoid material was diagnosed in one of the cases. Dentinoameloblastoma (DA) is an unusual OT characterized by classic ameloblast like areas with unusual formation of dentinoid by neoplastic epithelial cells of odontogenic origin. The World Health Organization first defined the term DA in 1970.\[[@ref23]\]

The variant of CEOT with clear cells was diagnosed in one of the cases. The first case of CEOT was described by Abrams and Howell in 1967 predominantly composed of clear cells.\[[@ref24]\] Krolls and Pindborg considered two of those 23 cases of CEOT as a challenge in diagnosis due to predominance of clear cells. Since then, the clear-cell component in CEOTs has been reported mainly through single cases and its prognostic importance is still debatable.\[[@ref24][@ref25][@ref26][@ref27][@ref28][@ref29][@ref30][@ref31]\]

CONCLUSION {#sec1-5}
==========

OTs are rare group of lesions in the population studied and are represented mainly by the Ameloblastoma, KCOT, AOT and O. The clinical and histopathologic features of these neoplasms differentiates it from other oral lesions. OTs exhibits a male preponderance, and most cases are diagnosed in the 1^st^--3^rd^ decades of life. Possible geographic variation of OTs was observed from the cases reviewed.
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